Advancing molecular-guided surgery through probe development and testing in a moderate cost evaluation pipeline

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 9311, Issue , 2015, Pages

  Pogue, Brian W ^a,b   Paulsen, Keith D ^a,b   Hull, Sally M ^a   Samkoe, Kimberly S ^a,b   Gunn, Jason ^a   Hoopes, Jack ^a,b   Roberts, David W ^a,b   Strong, Theresa V ^c   Draney, Daniel ^d   Feldwisch, Joachim ^e  

^a DARTMOUTH COLLEGE   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c University of Alabama at Birmingham   (United States)

^d LI COR BIOSCIENCES   (United States)

^e Affibody AB   (Sweden)

Author keywords

Affibody; Cancer; Emission; Filter; Fluorescence; Guidance; Intervention; Luminescence; Oncology; Surgery

Indexed keywords

ECONOMICS; ELECTRONIC GUIDANCE SYSTEMS; FLUORESCENCE; LUMINESCENCE; MOLECULES; NEUROSURGERY; NEUTRON EMISSION; ONCOLOGY; PIPELINES; SYNTHESIS (CHEMICAL);

AFFIBODY; CANCER; DEVELOPMENT AND TESTING; EPIDERMAL GROWTH FACTOR RECEPTORS; FILTER; FINANCIAL INVESTMENTS; INTERVENTION; THERAPEUTIC PARADIGMS;

SURGERY;

EID: 84924940331     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.2083224     Document Type: Conference Paper

References (40)

1. Keereweer, S., J.D. Kerrebijn, P.B. van Driel, B. Xie, E.L. Kaijzel, T.J. Snoeks, I. Que, M. Hutteman, J.R. van der Vorst, J.S. Mieog, A.L. Vahrmeijer, C.J. van de Velde, R.J. Baatenburg de Jong, and C.W. Lowik, Optical image-guided surgery-where do we stand? Mol Imaging Biol, 2011. 13(2): p. 199-207.
2. Tanaka, E., S. Ohnishi, R.G. Laurence, H.S. Choi, V. Humblet, and J.V. Frangioni, Real-time intraoperative ureteral guidance using invisible near-infrared fluorescence. J Urol, 2007. 178(5): p. 2197-202.
3. Sampath, L., S. Kwon, S. Ke, W. Wang, R. Schiff, M.E. Mawad, and E.M. Sevick-Muraca, Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer. J Nucl Med, 2007. 48(9): p. 1501-10.
4. Houston, J.P., S. Ke, W. Wang, C. Li, and E.M. Sevick-Muraca, Quality analysis of in vivo near-infrared fluorescence and conventional gamma images acquired using a dual-labeled tumor-targeting probe. J Biomed Opt, 2005. 10(5): p. 054010.
5. Marshall, M.V., D. Draney, E.M. Sevick-Muraca, and D.M. Olive, Single-dose intravenous toxicity study of IRDye 800CW in Sprague-Dawley rats. Mol Imaging Biol, 2010. 12(6): p. 583-94.
6. Nord, K., A combinatorial library of an alpha-helical bacterial receptor domain. Protein Eng, 1995. 8(6): p. 601-608.
7. Lofblom, J., J. Feldwisch, V. Tolmachev, J. Carlsson, S. Stahl, and F.Y. Frejd, Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications. FEBS Lett, 2010. 584(12): p. 2670-80.
8. Friedman, M., A. Orlova, E. Johansson, T.L. Eriksson, I. Hoiden-Guthenberg, V. Tolmachev, F.Y. Nilsson, and S. Stahl, Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptorbinding affibody molecule. J Mol Biol, 2008. 376(5): p. 1388-402.
9. Orlova, A., M. Magnusson, T.L. Eriksson, M. Nilsson, B. Larsson, I. Hoiden-Guthenberg, C. Widstrom, J. Carlsson, V. Tolmachev, S. Stahl, and F.Y. Nilsson, Tumor imaging using a picomolar affinity HER2 binding affibody molecule. Cancer Res, 2006. 66(8): p. 4339-48.
10. Lindborg, M., E. Cortez, I. Hoiden-Guthenberg, E. Gunneriusson, E. von Hage, F. Syud, M. Morrison, L. Abrahmsen, N. Herne, K. Pietras, and F.Y. Frejd, Engineered high-affinity affibody molecules targeting platelet-derived growth factor receptor beta in vivo. J Mol Biol, 2011. 407(2): p. 298-315.
11. Baum, R.P., V. Prasad, D. Muller, C. Schuchardt, A. Orlova, A. Wennborg, V. Tolmachev, and J. Feldwisch, Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68Ga-labeled affibody molecules. J Nucl Med, 2010. 51(6): p. 892-7.
12. Feldwisch, J., V. Tolmachev, C. Lendel, N. Herne, A. Sjoberg, B. Larsson, D. Rosik, E. Lindqvist, G. Fant, I. Hoiden-Guthenberg, J. Galli, P. Jonasson, and L. Abrahmsen, Design of an optimized scaffold for affibody molecules. J Mol Biol, 2010. 398(2): p. 232-47.
13. Ahlgren, S., A. Orlova, H. Wallberg, M. Hansson, M. Sandstrom, R. Lewsley, A. Wennborg, L. Abrahmsen, V. Tolmachev, and J. Feldwisch, Targeting of HER2-expressing tumors using 111In-ABY-025, a secondgeneration affibody molecule with a fundamentally reengineered scaffold. J Nucl Med, 2010. 51(7): p. 1131-8.
14. Ahlgren, S., H. Wallberg, T.A. Tran, C. Widstrom, M. Hjertman, L. Abrahmsen, D. Berndorff, L.M. Dinkelborg, J.E. Cyr, J. Feldwisch, A. Orlova, and V. Tolmachev, Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine. J Nucl Med, 2009. 50(5): p. 781-9.
15. Orlova, A., V. Tolmachev, R. Pehrson, M. Lindborg, T. Tran, M. Sandstrom, F.Y. Nilsson, A. Wennborg, L. Abrahmsen, and J. Feldwisch, Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors. Cancer Res, 2007. 67(5): p. 2178-86.
16. Peck, G.C., H.P. Mack, W.A. Holbrook, and F.H. Figge, Use of hematoporphyrin fluorescence in biliary and cancer surgery. Am Surg, 1955. 21(3): p. 181-8.
17. Wexner, S.D., R. Bergamaschi, A. Lacy, J. Udo, H. Brolmann, R.H. Kennedy, and H. John, The current status of robotic pelvic surgery: results of a multinational interdisciplinary consensus conference. Surg Endosc, 2009. 23(2): p. 438-43.
18. Autorino, R. and F.J. Kim, Urologic Laparoendoscopic Single-Site Surgery (LESS): current status. Urologia, 2011. 78(1): p. 32-41.
19. Horiguchi, A., I. Uyama, M. Ito, S. Ishihara, Y. Asano, T. Yamamoto, Y. Ishida, and S. Miyakawa, Robotassisted laparoscopic pancreatic surgery. J Hepatobiliary Pancreat Sci, 2011.
20. Rane, A. and R. Autorino, Robotic natural orifice translumenal endoscopic surgery and laparoendoscopic single-site surgery: current status. Curr Opin Urol, 2011. 21(1): p. 71-7.
21. Stuer, C., F. Ringel, M. Stoffel, A. Reinke, M. Behr, and B. Meyer, Robotic technology in spine surgery: current applications and future developments. Acta Neurochir Suppl, 2011. 109: p. 241-5.
22. Hagen, M.E., O.J. Wagner, I. Inan, P. Morel, J. Fasel, G. Jacobsen, A. Spivack, K. Thompson, B. Wong, L. Fischer, M. Talamini, and S. Horgan, Robotic single-incision transabdominal and transvaginal surgery: initial experience with intersecting robotic arms. Int J Med Robot, 2010. 6(3): p. 251-5.
23. Pleijhuis, R.G., G.C. Langhout, W. Helfrich, G. Themelis, A. Sarantopoulos, L.M. Crane, N.J. Harlaar, J.S. de Jong, V. Ntziachristos, and G.M. van Dam, Near-infrared fluorescence (NIRF) imaging in breast-conserving surgery: assessing intraoperative techniques in tissue-simulating breast phantoms. Eur J Surg Oncol, 2011. 37(1): p. 32-9.
24. De Grand, A.M. and J.V. Frangioni, An operational near-infrared fluorescence imaging system prototype for large animal surgery. Technol Cancer Res Treat, 2003. 2(6): p. 553-62.
25. Vahrmeijer, A.L. and J.V. Frangioni, Seeing the invisible during surgery. Br J Surg, 2011. 98(6): p. 749-50.
26. Orcutt, K.D., A.L. Slusarczyk, M. Cieslewicz, B. Ruiz-Yi, K.R. Bhushan, J.V. Frangioni, and K.D. Wittrup, Engineering an antibody with picomolar affinity to DOTA chelates of multiple radionuclides for pretargeted radioimmunotherapy and imaging. Nucl Med Biol, 2011. 38(2): p. 223-33.
27. Gibbs-Strauss, S.L., K.A. Nasr, K.M. Fish, O. Khullar, Y. Ashitate, T.M. Siclovan, B.F. Johnson, N.E. Barnhardt, C.A. Tan Hehir, and J.V. Frangioni, Nerve-highlighting fluorescent contrast agents for imageguided surgery. Mol Imaging, 2011. 10(2): p. 91-101.
28. Orcutt, K.D., M.E. Ackerman, M. Cieslewicz, E. Quiroz, A.L. Slusarczyk, J.V. Frangioni, and K.D. Wittrup, A modular IgG-scFv bispecific antibody topology. Protein Eng Des Sel, 2010. 23(4): p. 221-8.
29. Stummer, W., U. Pichlmeier, T. Meinel, O.D. Wiestler, F. Zanella, and H.J. Reulen, Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol, 2006. 7(5): p. 392-401.
30. Roberts, D.W., P.A. Valdes, B.T. Harris, K.M. Fontaine, A. Hartov, X. Fan, S. Ji, S.S. Lollis, B.W. Pogue, F. Leblond, T.D. Tosteson, B.C. Wilson, and K.D. Paulsen, Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between delta-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article. J Neurosurg, 2011. 114(3): p. 595-603.
31. Leung, K., IRDye 800-Labeled anti-epidermal growth factor receptor Affibody. 2004.
32. Chopra, A., Cy5.5 conjugated anti-epidermal growth factor receptor monoclonal antibody. 2004.
33. Leung, K., IRDye 800CW-Epidermal growth factor. 2004.
34. Helman, E.E., J.R. Newman, N.R. Dean, W. Zhang, K.R. Zinn, and E.L. Rosenthal, Optical imaging predicts tumor response to anti-EGFR therapy. Cancer Biol Ther, 2010. 10(2): p. 166-71.
35. Wang, K., W. Li, T. Huang, R. Li, D. Wang, B. Shen, and X. Chen, Characterizing breast cancer xenograft epidermal growth factor receptor expression by using near-infrared optical imaging. Acta Radiol, 2009. 50(10): p. 1095-103.
36. Gleysteen, J.P., J.R. Newman, D. Chhieng, A. Frost, K.R. Zinn, and E.L. Rosenthal, Fluorescent labeled anti-EGFR antibody for identification of regional and distant metastasis in a preclinical xenograft model. Head Neck, 2008. 30(6): p. 782-9.
37. Koyama, Y., T. Barrett, Y. Hama, G. Ravizzini, P.L. Choyke, and H. Kobayashi, In vivo molecular imaging to diagnose and subtype tumors through receptor-targeted optically labeled monoclonal antibodies. Neoplasia, 2007. 9(12): p. 1021-9.
38. Barrett, T., Y. Koyama, Y. Hama, G. Ravizzini, I.S. Shin, B.S. Jang, C.H. Paik, Y. Urano, P.L. Choyke, and H. Kobayashi, In vivo diagnosis of epidermal growth factor receptor expression using molecular imaging with a cocktail of optically labeled monoclonal antibodies. Clin Cancer Res, 2007. 13(22 Pt 1): p. 6639-48.
39. Kulbersh, B.D., R.D. Duncan, J.S. Magnuson, J.B. Skipper, K. Zinn, and E.L. Rosenthal, Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts. Arch Otolaryngol Head Neck Surg, 2007. 133(5): p. 511-5.
40. Rosenthal, E.L., B.D. Kulbersh, R.D. Duncan, W. Zhang, J.S. Magnuson, W.R. Carroll, and K. Zinn, In vivo detection of head and neck cancer orthotopic xenografts by immunofluorescence. Laryngoscope, 2006. 116(9): p. 1636-41.